Cobimetinib-progress in the treatment of melanoma
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Buka D. | cs |
dc.contributor.author | Abrahámová Jitka | cs |
dc.date.accessioned | 2018-09-25T12:18:17Z | |
dc.date.available | 2018-09-25T12:18:17Z | |
dc.date.issued | 2017 | cs |
dc.format.extent | 4 | cs |
dc.identifier.issn | 0862-8947 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31790 | |
dc.language.iso | cze | cs |
dc.publisher | Svoboda | cs |
dc.publisher.city | Praha | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | cobimetinib | cs |
dc.subject | vemurafenib | cs |
dc.subject | melanoma | cs |
dc.title | Cobimetinib-progress in the treatment of melanoma | en |
dc.title | Cobimetinib-pokrok v léčbě melanomu | cs |
local.citation.epage | 453-456 | cs |
local.citation.spage | 453-456 | cs |
local.identifier.publikace | 5259 | |
local.relation.issue | 5 | cs |